Recorded Presentations from the 2013 NCCN Nursing Program: Advancing Oncology Nursing™ Webinar Series

The 2013 Nursing Program: Advancing Oncology Nursing™ webinar series provides the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer. This program focuses on hereditary colorectal cancer, management of chemosensory dysfunction, management of adverse events in metastatic prostate cancer and metastatic breast cancer, risk assessment for VTE and thromboprophylaxis, and prevention and treatment of cancer-related infections. Oncology nurses will leave this program with information to provide the best clinical care and patient education to further improve their patients' quality of life.

Intended Audience
These activities are designed to meet the educational needs of oncology nurses who manage patients with cancer.

Accreditation
These activities are approved for nursing contact hours. Complete accreditation information is provided before each individual educational activity.

Fee Information
There is no fee for these activities.

Supporters
Supported by an educational donation provided by Amgen; Supported by educational grants from Genentech; Janssen Biotech, Inc. administered by Janssen Services, LLC; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; and Teva Pharmaceuticals.

Click the title of an activity below to proceed.

Course summary
Course opens: 
07/01/2013
Course expires: 
07/01/2014
Cost:
$0.00

Available Credit

Accreditation Period

Course opens: 
07/01/2013
Course expires: 
07/01/2014
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.